Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
1271
-
Total 13F shares, excl. options
-
92M
-
Shares change
-
-1.69M
-
Total reported value, excl. options
-
$58.3B
-
Value change
-
-$1.19B
-
Put/Call ratio
-
1.01
-
Number of buys
-
644
-
Number of sells
-
-590
-
Price
-
$634.23
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2025
1,504 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2025.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,271 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92M shares
of 105M outstanding shares and own 87.59% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.41M shares), BlackRock, Inc. (8.93M shares), FMR LLC (7.6M shares), JPMORGAN CHASE & CO (5.66M shares), STATE STREET CORP (4.79M shares), Capital International Investors (3.99M shares), GEODE CAPITAL MANAGEMENT, LLC (2.47M shares), Dodge & Cox (2.32M shares), FRANKLIN RESOURCES INC (2.28M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (2.18M shares).
This table shows the top 1271 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.